BioSpace News Archive

BioCapital

McKesson Medical-Surgical to Offer New Sysmex Device That Provides Blood Test Results at Point of Care in Minutes

Once prepared for each day’s use, the Sysmex XW-100 allows health care professionals to provide patients with blood test results in as few as three minutes.

February 5, 2018

·

4 min read

Policy

AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application (sNDA) for Feraheme (ferumoxytol injection)

This sNDA approval immediately doubles the number of patients who could benefit from Feraheme to include both CKD and non-CKD patients.

February 5, 2018

·

6 min read

Chi-Med to Announce 2017 Final Results

Chi-Med will be announcing its final results for the year ended December 31, 2017 on Monday, March 12, 2018 at 7:00 am Greenwich Mean Time.

February 5, 2018

·

1 min read

Genetown

New Data and Surgical Experiences With OMNIBotics Active Spacer Ligament Balancing System Presented at Prestigious Orthopaedics Conference

The more than 150 attendees learned about OMNIBotics Active Spacer technology in both a pre-recorded surgery presentation and a podium presentation.

February 5, 2018

·

4 min read

Pharm Country

ContraVir Pharmaceuticals Receives Positive Nasdaq Listing Determination

The company is taking definitive steps to satisfy the terms of the Panel’s decision.

February 5, 2018

·

3 min read

Biotech Bay

UC Santa Cruz Scientists Report Big Improvements in HIV Vaccine Production

Berman, the Baskin Professor of Biomolecular Engineering at UC Santa Cruz, has now developed new methods for the production of HIV vaccines. His approach solves major technical problems which have bedeviled the field.

February 5, 2018

·

5 min read

Business

Ligand to Report Fourth Quarter and Full Year 2017 Results on February 21st

Ligand’s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg will host the conference call.

February 5, 2018

·

2 min read

Business

BIO’s Statement on the Confirmation of Andrei Iancu to Lead the U.S. Patent and Trademark Office

The following statement may be attributed to BIO President & CEO James Greenwood: “I congratulate Andrei Iancu on his Senate confirmation to fill the position of Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (PTO).”

February 5, 2018

·

1 min read

Business

Bio-Path Holdings Appoints Paul Aubert to its Board of Directors

Mr. Aubert is currently the sole Shareholder at Paul Aubert PLLC.

February 5, 2018

·

2 min read

Drug Development

Fibrocell Announces Submission of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized Scleroderma

The FDA has granted Orphan Drug Designation to FCX-013 for the treatment of localized scleroderma.

February 5, 2018

·

6 min read